361 related articles for article (PubMed ID: 9892022)
1. P450c17 mutations R347H and R358Q selectively disrupt 17,20-lyase activity by disrupting interactions with P450 oxidoreductase and cytochrome b5.
Geller DH; Auchus RJ; Miller WL
Mol Endocrinol; 1999 Jan; 13(1):167-75. PubMed ID: 9892022
[TBL] [Abstract][Full Text] [Related]
2. Pitfalls in characterizing P450c17 mutations associated with isolated 17,20-lyase deficiency.
Gupta MK; Geller DH; Auchus RJ
J Clin Endocrinol Metab; 2001 Sep; 86(9):4416-23. PubMed ID: 11549685
[TBL] [Abstract][Full Text] [Related]
3. Cytochrome b5 augments the 17,20-lyase activity of human P450c17 without direct electron transfer.
Auchus RJ; Lee TC; Miller WL
J Biol Chem; 1998 Feb; 273(6):3158-65. PubMed ID: 9452426
[TBL] [Abstract][Full Text] [Related]
4. The molecular basis of isolated 17,20 lyase deficiency.
Miller WL; Geller DH; Auchus RJ
Endocr Res; 1998; 24(3-4):817-25. PubMed ID: 9888582
[TBL] [Abstract][Full Text] [Related]
5. Steroid 17 alpha-hydroxylase and 17,20-lyase activities of P450c17: contributions of serine106 and P450 reductase.
Lin D; Black SM; Nagahama Y; Miller WL
Endocrinology; 1993 Jun; 132(6):2498-506. PubMed ID: 8504753
[TBL] [Abstract][Full Text] [Related]
6. Regulation of 17,20 lyase activity by cytochrome b5 and by serine phosphorylation of P450c17.
Pandey AV; Miller WL
J Biol Chem; 2005 Apr; 280(14):13265-71. PubMed ID: 15687493
[TBL] [Abstract][Full Text] [Related]
7. A Homodimer Model Can Resolve the Conundrum as to How Cytochrome P450 Oxidoreductase and Cytochrome b5 Compete for the Same Binding Site on Cytochrome P450c17.
Holien JK; Parker MW; Conley AJ; Corbin CJ; Rodgers RJ; Martin LL
Curr Protein Pept Sci; 2017; 18(5):515-521. PubMed ID: 28000554
[TBL] [Abstract][Full Text] [Related]
8. NADPH-flavodoxin reductase and flavodoxin from Escherichia coli: characteristics as a soluble microsomal P450 reductase.
Jenkins CM; Waterman MR
Biochemistry; 1998 Apr; 37(17):6106-13. PubMed ID: 9558349
[TBL] [Abstract][Full Text] [Related]
9. Assessment of the ability of type 2 cytochrome b5 to modulate 17,20-lyase activity of human P450c17.
Soucy P; Luu-The V
J Steroid Biochem Mol Biol; 2002 Jan; 80(1):71-5. PubMed ID: 11867265
[TBL] [Abstract][Full Text] [Related]
10. Conversion of pregnenolone to DHEA by human 17alpha-hydroxylase/17, 20-lyase (P450c17). Evidence that DHEA is produced from the released intermediate, 17alpha-hydroxypregnenolone.
Soucy P; Luu-The V
Eur J Biochem; 2000 Jun; 267(11):3243-7. PubMed ID: 10824109
[TBL] [Abstract][Full Text] [Related]
11. Differential inhibition of 17alpha-hydroxylase and 17,20-lyase activities by three novel missense CYP17 mutations identified in patients with P450c17 deficiency.
Van Den Akker EL; Koper JW; Boehmer AL; Themmen AP; Verhoef-Post M; Timmerman MA; Otten BJ; Drop SL; De Jong FH
J Clin Endocrinol Metab; 2002 Dec; 87(12):5714-21. PubMed ID: 12466376
[TBL] [Abstract][Full Text] [Related]
12. Human cytochrome b5 requires residues E48 and E49 to stimulate the 17,20-lyase activity of cytochrome P450c17.
Naffin-Olivos JL; Auchus RJ
Biochemistry; 2006 Jan; 45(3):755-62. PubMed ID: 16411751
[TBL] [Abstract][Full Text] [Related]
13. The role of cytochrome b5 in the biosynthesis of androgens by human P450c17.
Katagiri M; Kagawa N; Waterman MR
Arch Biochem Biophys; 1995 Mar; 317(2):343-7. PubMed ID: 7893148
[TBL] [Abstract][Full Text] [Related]
14. Biochemical differences between rat and human cytochrome P450c17 support the different steroidogenic needs of these two species.
Brock BJ; Waterman MR
Biochemistry; 1999 Feb; 38(5):1598-606. PubMed ID: 9931027
[TBL] [Abstract][Full Text] [Related]
15. The regulation of 17,20 lyase activity.
Miller WL; Auchus RJ; Geller DH
Steroids; 1997 Jan; 62(1):133-42. PubMed ID: 9029728
[TBL] [Abstract][Full Text] [Related]
16. Kinetic processivity of the two-step oxidations of progesterone and pregnenolone to androgens by human cytochrome P450 17A1.
Gonzalez E; Guengerich FP
J Biol Chem; 2017 Aug; 292(32):13168-13185. PubMed ID: 28684414
[TBL] [Abstract][Full Text] [Related]
17. Assessment of porcine and human 16-ene-synthase, a third activity of P450c17, in the formation of an androstenol precursor. Role of recombinant cytochrome b5 and P450 reductase.
Soucy P; Lacoste L; Luu-The V
Eur J Biochem; 2003 Mar; 270(6):1349-55. PubMed ID: 12631293
[TBL] [Abstract][Full Text] [Related]
18. Molecular modeling of human P450c17 (17alpha-hydroxylase/17,20-lyase): insights into reaction mechanisms and effects of mutations.
Auchus RJ; Miller WL
Mol Endocrinol; 1999 Jul; 13(7):1169-82. PubMed ID: 10406467
[TBL] [Abstract][Full Text] [Related]
19. Tight binding of cytochrome b
Kim D; Kim V; McCarty KD; Guengerich FP
J Biol Chem; 2021; 296():100571. PubMed ID: 33753170
[TBL] [Abstract][Full Text] [Related]
20. Cytochrome b5 Activates the 17,20-Lyase Activity of Human Cytochrome P450 17A1 by Increasing the Coupling of NADPH Consumption to Androgen Production.
Peng HM; Im SC; Pearl NM; Turcu AF; Rege J; Waskell L; Auchus RJ
Biochemistry; 2016 Aug; 55(31):4356-65. PubMed ID: 27426448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
